Iontophoretic drug delivery system with two-stage delivery profile.
Abstract
A two-stage iontophoretic drug delivery system provides that iontophoretic current is delivered at a first level for a first predetermined interval to rapidly introduce a therapeutic agent into the bloodstream and thereafter reduced to a second lower level to maintain a desired steady-state therapeutic level of the agent. One embodiment provides that the initial interval is maintained sufficiently long to provide a peak dosage, thereafter which the current is shut off to allow concentration of the agent to subside in the bloodstream, whereupon a maintenance level of iontophoretic current is initiated. Another embodiment provides that the patient may selectively initiate a brief interval of increased iontophoretic current level to attain a brief interval of increased dosage.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
23 members in 14 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 50217690 | United States of America | A | |
| 67130691 | United States of America | A | |
| 9101941 | United States of America | W | |
| 91671306 | – | – | – |
| US19900502176 | – | – | – |
| US19910671306 | – | – | – |
| WO1991US01941 | – | – | – |
Members23
| Document | Office | Kind | |
|---|---|---|---|
| CA2079316A1 | Canada | A1 | |
| WO9115258A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7991591A | Australia | A | |
| FI924352A | Finland | A | |
| NO923769D0 | Norway | D0 | |
| NO923769LThis record | Norway | L | |
| EP0522092A1 | European Patent Office (EPO) | A1 | |
| KR930700181A | Republic of Korea | A | |
| US5207752A | United States of America | A | |
| AU638581B2 | Australia | B2 | |
| JPH05505964A | Japan | A | |
| EP0522092B1 | European Patent Office (EPO) | B1 | |
| AT114118T | Austria | T | |
| DE69105202D1 | Germany | D1 | |
| DK0522092T3 | Denmark | T3 | |
| DE69105202T2 | Germany | T2 | |
| ES2067939T3 | Spain | T3 | |
| GR3015116T3 | Greece | T3 | |
| KR0169084B1 | Republic of Korea | B1 | |
| NO308025B1 | Norway | B1 | |
| JP3181289B2 | Japan | B2 | |
| CA2079316C | Canada | C | |
| FI110066B | Finland | B |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Patent expiredExpiredMK1K | MK1K |
Numbers
- Publication, DOCDB
- 923769
- Publication, EPODOC
- NO923769L
- Application
- 92923769
- Application, DOCDB
- 923769
- Application, EPODOC
- NO19920003769
Titles
- Norwegian
- SYSTEM FOR IONTOFORETISK TILFOERSEL AV ET MEDIKAMENT
Classification
- CPC, 2
- A61N1/0428
- A61N1/325
- IPC, 2
- A61N1 30
- A61N1 32